Major domestic pharmaceutical firms eye 18.7% growth in turnover

The 23 major domestic pharmaceutical firms set their turnover growth rate this year at 18.7 percent on average (combined turnover: 4.1 trillion won) compared with 3.5 trillion won (estimated), according to the analyses on 2003 management strategies of chief executives officers of major drug manufacturing firms conducted by Yakup Shimoon.

Their turnover growth targets for this year are lower ...